{"schema_version":"secwatch.filing_event.v1","accession":"0001619856-24-000050","form_type":"8-K","ticker":"CRBU","cik":"0001619856","company_name":"Caribou Biosciences, Inc.","filed_at":"2024-06-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.280380+00:00","generated_at":"2026-06-01T04:20:14.955454+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Caribou Biosciences stockholders elect three directors and ratify auditor at 2024 annual meeting","bullets":["Elected Class III directors: Rachel Haurwitz (57.4M for), Dara Richardson-Heron (50.2M for), Natalie Sacks (50.2M for).","Ratified Deloitte & Touche as independent auditor for FY 2024 with 73.0M votes for, 0.2M against.","Broker non-votes of 13.6M shares on director elections; no broker votes on auditor ratification.","Annual meeting held June 13, 2024; all proposals passed as recommended by the board."],"urls":{"canonical":"https://secwatch.observer/filing/0001619856-24-000050","json":"https://secwatch.observer/filing/0001619856-24-000050.json","markdown":"https://secwatch.observer/filing/0001619856-24-000050.md","text":"https://secwatch.observer/filing/0001619856-24-000050.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1619856/000161985624000050/0001619856-24-000050-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1619856/000161985624000050/crbu-20240613.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:20:14.955454+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}